Tag Archives | Pharmaceuticals

Pharma Moves To Make OxyContin For Kids

For when a bandaid isn’t enough. Via The Daily:

The maker of OxyContin is seeking Food and Drug Administration approval to label the controversial painkiller for use by children as young as 6 in a move that could serve to extend the company’s expiring patent on the lucrative drug.

Purdue Pharma has paid dozens of clinical sites around the country to document what happens when OxyContin, an addictive pharmaceutical widely abused by recreational users, is given to children. The family-owned pharmaceutical company earned an estimated $2.8 billion in revenue last year from sales of the powerful opioid, part of the same drug family as morphine and heroin.

 

Read the rest

Continue Reading

Nationwide Shortage Of Ritalin And Adderall

800px-RitalinIn November Jacob Sloan posted a story about a chronic shortage of Adderall in New York City. Now the New York Times reports that the shortage extends to Ritalin and generic versions, nationwide:

Medicines to treat attention deficit hyperactivity disorder are in such short supply that hundreds of patients complain daily to the Food and Drug Administration that they are unable to find a pharmacy with enough pills to fill their prescriptions.

The shortages are a result of a troubled partnership between drug manufacturers and the Drug Enforcement Administration, with companies trying to maximize their profits and drug enforcement agents trying to minimize abuse by people, many of them college students, who use the medications to get high or to stay up all night.

Caught in between are millions of children and adults who rely on the pills to help them stay focused and calm. Shortages, particularly of cheaper generics, have become so endemic that some patients say they worry almost constantly about availability.

Read the rest
Continue Reading

America’s Concentration Threatened By Adderall Shortage

2310749647_339fa45387Is Adderall the crystal meth of the middle and upper classes? Well, both drugs became huge at around the same time. The Fix writes that prices are skyrocketing and panic and withdrawal are setting in across the nation as pharmacies’ shelves run short:

When Jay V.’s pharmacist told him about the nationwide Adderall shortages last weekend, he reacted as any economically rational finance professional would, and attempted to bribe her. Whatever the cost, “it’s cheaper than cocaine,” his reasoning went. And even if it isn’t, you can’t put a price on never having to go back to doing bumps in the work bathroom to get through late night deal committee meetings, can you?

Jay’s pharmacist said she was reserving her supply for regular customers, but that the price had doubled and the clock was ticking.

If addiction is the kind of thing you think about a lot, it’s easy to overlook its significance in the cold, objective Realpolitik scheme of things, which is this: it’s a great fucking business model.

Read the rest
Continue Reading

Big Pharma Has No Idea What the Hell Their Drug Will Do to You

Pharma DrugsKyle Wagner writes on Gizmodo:
Everyone's cracked wise about cheerful voices in commercials telling us that an erectile dysfunction drug might make you blind, but have you ever read the full list of side effects? Prescription medication labels average an insane 70 possible side effects, according to a new study. The study examined 5,600 medications, and found the worst offenders to be antidepressants, antiviral medications, and restless leg syndrome medications treatments. One especially ridiculous drug listed 525. The exhaustive lists fly in the face of FDA guidelines asking drug companies to keep the lists manageable. Obviously, 525 is a preposterous number of side effects to list on a label, but isn't it just as concerning that we're prescribing drugs that could go wrong in 500 different ways?
Continue Reading

Will Big Pharma Take Over The American Market For Medical Marijuana?

MedMarjIf the hundreds of uses for cannabis doesn’t plead the case for its legalization, the money made from its medical industry just might do it. The Washington Independent reports:

The American Independent has previously reported on the growing corporatization of the incipient medical marijuana industry at a time when medical marijuana dispensaries scrabble to hold on to their businesses in the face of a multi-pronged federal crackdown. But there are signs afoot that it just may become ever more corporate if a Big Pharma push to get the U.S. Food and Drug Administration to recognize a cannabis-derived drug is successful.

Last week, British prescription drug manufacturer GW Pharmaceuticals announced a licensing agreement with drug giant Novartis, maker of Ritalin and Excedrin, to begin selling GW’s drug Sativex in markets across Asia, Africa, Oceania and the Middle East. The medication is already available in Britain, where it’s produced and marketed by Bayer, and in Canada and Spain.

Read the rest
Continue Reading